Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT00706212
Status:
UNKNOWN
Last Update Posted:
2008-06-27
First Post:
2008-06-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 60}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2008-06'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2008-05', 'lastUpdateSubmitDate': '2008-06-26', 'studyFirstSubmitDate': '2008-06-26', 'studyFirstSubmitQcDate': '2008-06-26', 'lastUpdatePostDateStruct': {'date': '2008-06-27', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2008-06-27', 'type': 'ESTIMATED'}}, 'conditionsModule': {'conditions': ['Urological Malignancies']}, 'descriptionModule': {'briefSummary': 'PET CT is one of the imaging tools that are used for staging of urological malignancies.\n\nC11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed \\~95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Rabin Medical center Urological oncology patients', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients older then 18 years of age\n* Full consciousness and awareness\n* suspected to suffer from urological malignancy and a candidate for a surgical procedur\n\nExclusion Criteria:\n\n* known secondary malignancy'}, 'identificationModule': {'nctId': 'NCT00706212', 'acronym': 'GS-PET-2008', 'briefTitle': 'The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies', 'organization': {'class': 'OTHER', 'fullName': 'Rabin Medical Center'}, 'officialTitle': 'A Comparative Study to Examine the Accuracy of CHOLINE PET CT in the Diagnosis', 'orgStudyIdInfo': {'id': 'GS-PET-2008'}}, 'contactsLocationsModule': {'locations': [{'zip': '49100', 'city': 'Petah Tikva', 'status': 'RECRUITING', 'country': 'Israel', 'contacts': [{'name': 'Shay Golan, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Rabin Medical Center, Beilinson hospital', 'geoPoint': {'lat': 32.08707, 'lon': 34.88747}}], 'centralContacts': [{'name': 'Shay Golan, MD', 'role': 'CONTACT', 'email': 'shaygo1@yahoo.com', 'phone': '972-50-744-7573'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Rabin Medical Center', 'class': 'OTHER'}, 'responsibleParty': {'oldNameTitle': 'Dr. Golan Shay', 'oldOrganization': 'Rabin Medical Center, Urology department'}}}}